TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00344682

Adverse event: Dyspnoea
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 16 at risk

Adverse event: Anxiety
Serious: no
Organ System: Psychiatric disorders
Frequency: 3 affected / 16 at risk

Adverse event: Irritability
Serious: no
Organ System: Psychiatric disorders
Frequency: 2 affected / 16 at risk

Adverse event: Dyspnoea
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 15 at risk

Adverse event: Anxiety
Serious: no
Organ System: Psychiatric disorders
Frequency: 3 affected / 15 at risk

Adverse event: Irritability
Serious: no
Organ System: Psychiatric disorders
Frequency: 2 affected / 15 at risk
Study: NCT00345033

Adverse event: eye irritation/swelling
Serious: no
Organ System: Eye disorders
Notes: Subject visited Mass Eye and Ear with eye swelling and irritation. He was given Visine Tears after which the swelling and irritation resolved.
Frequency: 1 affected / 16 at risk

Adverse event: Psychiatric decompensation
Serious: no
Organ System: Psychiatric disorders
Notes: Subject stayed at McLean Hospital for psychiatric evaluation over 1 night. His medications were not changed. He was seen by his psychiatrist 6 days later who confirmed that subject was doing well. Subject was admitted prior to any study procedures.
Frequency: 1 affected / 16 at risk

Adverse event: Psychiatric decompensation
Serious: no
Organ System: Psychiatric disorders
Notes: Subject was hospitalized at BI after worsening psychiatric symptoms. It was discovered that subject was taking a lesser dosage than proscribed of his antipsychotic. Subject's dosage was adjusted and he was released.
Frequency: 1 affected / 16 at risk

Adverse event: Psychiatric decompensation
Serious: no
Organ System: Psychiatric disorders
Notes: Subject stopped taking all of his medications including study medication, and was hospitalized after worsening psychiatric symptoms. Subject was terminated from the study.
Frequency: 1 affected / 16 at risk

Adverse event: dizziness during IVGTT procedure
Serious: no
Organ System: General disorders
Notes: Subject experienced dizziness and hunger during IVGTT procedure. He was given orange juice and food, and the symptoms had resolved by the time he left the hospital. Coordinator contacted subject later that afternoon who reported feeling fine.
Frequency: 1 affected / 14 at risk

Adverse event: Asthma
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Notes: Subject experienced asthma attack. Subject has a history of asthma. Subject was given two nebulizer treatments at urgent care, which resolved the symptom, and she was released the same night. Subject was proscribed Adviar.
Frequency: 1 affected / 14 at risk

Adverse event: Abdominal pain upper
Serious: no
Organ System: Gastrointestinal disorders
Notes: Subject called ambulance for stomach pain. She was given Maalox at the ER, which resolved the symptom, and she was discharged.
Frequency: 1 affected / 14 at risk
Study: NCT00345332

Adverse event: Urinary tract infection
Serious: no
Organ System: Infections and infestations
Frequency: 3 affected / 11 at risk

Adverse event: Urinary tract infection
Serious: no
Organ System: Infections and infestations
Frequency: 11 affected / 20 at risk

Adverse event: post void retention volumes > 200cc
Serious: no
Organ System: Renal and urinary disorders
Frequency: 5 affected / 20 at risk
Study: NCT00345371

Adverse event: Anaemia
Serious: yes
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 69 at risk

Adverse event: Diverticulitis
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 69 at risk

Adverse event: Infected Boil
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 69 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 33 affected / 69 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Frequency: 20 affected / 69 at risk

Adverse event: Cough
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 16 affected / 69 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 11 affected / 69 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Frequency: 9 affected / 69 at risk

Adverse event: Superficial Cutting
Serious: yes
Organ System: Psychiatric disorders
Frequency: 1 affected / 71 at risk

Adverse event: Malignant hypertention (with angina)
Serious: yes
Organ System: Cardiac disorders
Frequency: 1 affected / 71 at risk

Adverse event: Visual impairment
Serious: yes
Organ System: Eye disorders
Frequency: 1 affected / 71 at risk

Adverse event: Dyspnoea
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 71 at risk

Adverse event: Physical assault
Serious: yes
Organ System: Social circumstances
Frequency: 1 affected / 71 at risk

Adverse event: Pregnancy
Serious: yes
Organ System: Pregnancy, puerperium and perinatal conditions
Frequency: 1 affected / 71 at risk

Adverse event: Electrocardiogram abnormal
Serious: yes
Organ System: Cardiac disorders
Frequency: 1 affected / 71 at risk

Adverse event: Disorientation
Serious: yes
Organ System: Psychiatric disorders
Frequency: 1 affected / 71 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 30 affected / 71 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Frequency: 14 affected / 71 at risk

Adverse event: Cough
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 11 affected / 71 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 8 affected / 71 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Frequency: 5 affected / 71 at risk
Study: NCT00345384

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 7 affected / 19 at risk

Adverse event: Hypotension
Serious: no
Organ System: Cardiac disorders
Notes: systolic BP \< 90 Mm Hg
Frequency: 1 affected / 19 at risk

Adverse event: Bradycardia
Serious: no
Organ System: Cardiac disorders
Notes: heart rate \< 50 bpm
Frequency: 2 affected / 19 at risk

Adverse event: Tacycardia
Serious: no
Organ System: Cardiac disorders
Notes: Heart rate \> 110 bpm
Frequency: 3 affected / 19 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 3 affected / 19 at risk

Adverse event: Hypotension
Serious: no
Organ System: Cardiac disorders
Notes: systolic BP \< 90 Mm Hg
Frequency: 1 affected / 19 at risk

Adverse event: Tacycardia
Serious: no
Organ System: Cardiac disorders
Notes: Heart rate \> 110 bpm
Frequency: 1 affected / 19 at risk
Study: NCT00345397

Adverse event: Death, unrelated
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Notes: Pneumonia death during follow-up period
Frequency: 1 affected / 7 at risk

Adverse event: Hyponatraemia
Serious: no
Organ System: Renal and urinary disorders
Frequency: 1 affected / 7 at risk

Adverse event: Fistula
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 7 at risk
Study: NCT00345592

Adverse event: Atrial fibrillation
Serious: yes
Organ System: Cardiac disorders
Frequency: 10 affected / 199 at risk

Adverse event: worsening of cardiac disorders
Serious: yes
Organ System: Cardiac disorders
Notes: events leading to death
Frequency: 16 affected / 199 at risk

Adverse event: hopspitalizatin/intervention
Serious: yes
Organ System: General disorders
Notes: including cardiac and non cardiac hospitalizations
Frequency: 78 affected / 199 at risk

Adverse event: Transplant
Serious: yes
Organ System: Cardiac disorders
Frequency: 6 affected / 199 at risk

Adverse event: worsening of non-cardiac disorders
Serious: yes
Organ System: General disorders
Notes: events leading to death
Frequency: 8 affected / 199 at risk

Adverse event: worsening of unknown conditions leading to death
Serious: yes
Organ System: General disorders
Notes: include all the events leading to out of hospital death for unknown or undetermined conditions
Frequency: 13 affected / 199 at risk

Adverse event: device reprogramming
Serious: no
Organ System: Cardiac disorders
Notes: need to change device settings due to patient sysmptoms or adverse device effect, without invasive intervention
Frequency: 16 affected / 199 at risk

Adverse event: clinical observation
Serious: no
Organ System: General disorders
Notes: not requiring intervention
Frequency: 24 affected / 199 at risk

Adverse event: Atrial fibrillation
Serious: yes
Organ System: Cardiac disorders
Frequency: 7 affected / 197 at risk

Adverse event: worsening of cardiac disorders
Serious: yes
Organ System: Cardiac disorders
Notes: events leading to death
Frequency: 14 affected / 197 at risk

Adverse event: hopspitalizatin/intervention
Serious: yes
Organ System: General disorders
Notes: including cardiac and non cardiac hospitalizations
Frequency: 58 affected / 197 at risk

Adverse event: Transplant
Serious: yes
Organ System: Cardiac disorders
Frequency: 4 affected / 197 at risk

Adverse event: worsening of non-cardiac disorders
Serious: yes
Organ System: General disorders
Notes: events leading to death
Frequency: 10 affected / 197 at risk

Adverse event: worsening of unknown conditions leading to death
Serious: yes
Organ System: General disorders
Notes: include all the events leading to out of hospital death for unknown or undetermined conditions
Frequency: 7 affected / 197 at risk

Adverse event: device reprogramming
Serious: no
Organ System: Cardiac disorders
Notes: need to change device settings due to patient sysmptoms or adverse device effect, without invasive intervention
Frequency: 14 affected / 197 at risk

Adverse event: clinical observation
Serious: no
Organ System: General disorders
Notes: not requiring intervention
Frequency: 8 affected / 197 at risk
Study: NCT00345605

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 12 at risk

Adverse event: Hyperammonaemia
Serious: no
Organ System: Metabolism and nutrition disorders
Frequency: 1 affected / 12 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 12 at risk

Adverse event: Hyperammonaemia
Serious: no
Organ System: Metabolism and nutrition disorders
Frequency: 1 affected / 12 at risk
Study: NCT00345631

Adverse event: Rebleeding Following Initial Hemostasis
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 3 affected / 87 at risk

Adverse event: Access Site Hematoma >= 6cm
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 3 affected / 87 at risk

Adverse event: Access Site-Related Bleeding Requiring > 30 min for Hemostasis
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 87 at risk

Adverse event: Eochymosis >= 6cm
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 87 at risk

Adverse event: Decrease in Pedal Pulse
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 87 at risk

Adverse event: Rebleeding Following Initial Hemostasis
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 14 affected / 267 at risk

Adverse event: Access Site Hematoma >= 6cm
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 6 affected / 267 at risk

Adverse event: Access Site-Related Bleeding Requiring > 30 min for Hemostasis
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 267 at risk

Adverse event: Transient Access Site-Related Nerve Injury
Serious: no
Organ System: Nervous system disorders
Frequency: 1 affected / 267 at risk

Adverse event: Retroperitoneal haemorrhage
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 2 affected / 267 at risk

Adverse event: Rebleeding Following Initial Hemostasis
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 3 affected / 134 at risk

Adverse event: Access Site Hematoma >= 6cm
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 134 at risk

Adverse event: Access Site-Related Bleeding Requiring > 30 min for Hemostasis
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 134 at risk

Adverse event: Eochymosis >= 6cm
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 134 at risk
Study: NCT00345800

Adverse event: Rectal haemorrhage
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 25 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 5 affected / 25 at risk

Adverse event: Abdominal pain upper
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 3 affected / 25 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 2 affected / 25 at risk

Adverse event: Arthralgia
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 2 affected / 25 at risk

Adverse event: Osteoarthritis
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 2 affected / 25 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 6 affected / 25 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Frequency: 2 affected / 25 at risk

Adverse event: Anxiety
Serious: no
Organ System: Psychiatric disorders
Frequency: 2 affected / 25 at risk

Adverse event: Cough
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 2 affected / 25 at risk

Adverse event: Hyperhidrosis
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 2 affected / 25 at risk
Study: NCT00345969

Adverse event: Fall
Serious: no
Organ System: General disorders
Notes: Participant experienced a fall during balance testing; no injury sustained.
Frequency: 1 affected / 12 at risk

Adverse event: Atrial fibrillation
Serious: yes
Organ System: Cardiac disorders
Notes: Participant experienced new onset atrial fibrillation that required acute care hospitalization. The patient's symptoms occurred at rest and were not coincident with performing exercise.
Frequency: 1 affected / 13 at risk

Adverse event: Elevated serum PSA level
Serious: no
Organ System: Renal and urinary disorders
Notes: Participant had elevated PSA level (7.2 ng/mL) at month 6 of study, which returned to normal at 30-day follow up.
Frequency: 1 affected / 13 at risk
Study: NCT00346034

Adverse event: Diarrhoea
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 357 at risk

Adverse event: Melaena
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 357 at risk

Adverse event: Vomiting
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 357 at risk

Adverse event: Urinary tract infection
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 357 at risk

Adverse event: Fall
Serious: yes
Organ System: Injury, poisoning and procedural complications
Frequency: 1 affected / 357 at risk

Adverse event: Wrist fracture
Serious: yes
Organ System: Injury, poisoning and procedural complications
Frequency: 1 affected / 357 at risk

Adverse event: Spinal osteoarthritis
Serious: yes
Organ System: Injury, poisoning and procedural complications
Frequency: 1 affected / 357 at risk

Adverse event: Myoclonus
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 357 at risk

Adverse event: Vulva cyst
Serious: yes
Organ System: Reproductive system and breast disorders
Frequency: 1 affected / 357 at risk

Adverse event: Epistaxis
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 357 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Frequency: 85 affected / 357 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 33 affected / 357 at risk

Adverse event: Somnolence
Serious: no
Organ System: Nervous system disorders
Frequency: 30 affected / 357 at risk

Adverse event: Vertigo
Serious: no
Organ System: Ear and labyrinth disorders
Frequency: 12 affected / 357 at risk

Adverse event: Constipation
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 15 affected / 357 at risk

Adverse event: Dry mouth
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 14 affected / 357 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 21 affected / 357 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 13 affected / 357 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Frequency: 24 affected / 357 at risk

Adverse event: Oedema peripheral
Serious: no
Organ System: General disorders
Frequency: 12 affected / 357 at risk

Adverse event: Nasopharyngitis
Serious: no
Organ System: Infections and infestations
Frequency: 11 affected / 357 at risk

Adverse event: Weight increased
Serious: no
Organ System: Investigations
Frequency: 14 affected / 357 at risk
Study: NCT00346164

Adverse event: Second primary malignancy
Serious: yes
Organ System: Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Frequency: 1 affected / 17 at risk

Adverse event: Upper gastrointestinal haemorrhage
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 110 at risk

Adverse event: Encephalopathy
Serious: no
Organ System: Nervous system disorders
Frequency: 1 affected / 110 at risk

Adverse event: Hypotension
Serious: no
Organ System: Vascular disorders
Frequency: 1 affected / 110 at risk

Adverse event: Death
Serious: yes
Organ System: General disorders
Frequency: 1 affected / 196 at risk

Adverse event: Infections and infestations - Other, specify
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 196 at risk

Adverse event: Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
Serious: yes
Organ System: Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Frequency: 1 affected / 196 at risk

Adverse event: Cardiac disorders - Other, specify
Serious: no
Organ System: Cardiac disorders
Frequency: 1 affected / 196 at risk

Adverse event: Radiation skin injury
Serious: no
Organ System: Injury, poisoning and procedural complications
Frequency: 1 affected / 196 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 196 at risk

Adverse event: Encephalopathy
Serious: no
Organ System: Nervous system disorders
Frequency: 1 affected / 196 at risk

Adverse event: General disorders and administration site conditions - Other, specify
Serious: no
Organ System: General disorders
Frequency: 1 affected / 196 at risk

Adverse event: Hepatic infection
Serious: no
Organ System: Infections and infestations
Frequency: 1 affected / 196 at risk

Adverse event: Hypokalaemia
Serious: no
Organ System: Metabolism and nutrition disorders
Frequency: 1 affected / 196 at risk

Adverse event: Hypotension
Serious: no
Organ System: Vascular disorders
Frequency: 1 affected / 196 at risk

Adverse event: Pericardial effusion
Serious: no
Organ System: Cardiac disorders
Frequency: 1 affected / 196 at risk

Adverse event: Seizure
Serious: no
Organ System: Nervous system disorders
Frequency: 1 affected / 196 at risk

Adverse event: Skin ulcer
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 196 at risk

Adverse event: Embolism
Serious: no
Organ System: Vascular disorders
Frequency: 1 affected / 196 at risk

Adverse event: Wound dehiscence
Serious: no
Organ System: Injury, poisoning and procedural complications
Frequency: 1 affected / 196 at risk
Study: NCT00346333

Adverse event: Death
Serious: yes
Organ System: Injury, poisoning and procedural complications
Frequency: 1 affected / 121 at risk

Adverse event: Hepatic enzyme increased
Serious: yes
Organ System: Metabolism and nutrition disorders
Frequency: 1 affected / 119 at risk
Study: NCT00346697

Adverse event: Gastrointesitnal Side effects (dyspepsia, bloating, fishy taste)
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 3 affected / 24 at risk

Adverse event: Rash
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 24 at risk

Adverse event: Gastrointesitnal Side effects (dyspepsia, bloating, fishy taste)
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 6 affected / 24 at risk

Adverse event: Rash
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 2 affected / 24 at risk
Study: NCT00347438

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 3 affected / 16 at risk

Adverse event: Rash
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 16 at risk

Adverse event: Palmar-plantar erythrodysaesthesia syndrome
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 12 affected / 16 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Frequency: 1 affected / 16 at risk

Adverse event: Dizziness
Serious: no
Organ System: Nervous system disorders
Frequency: 1 affected / 16 at risk

Adverse event: Decreased appetite
Serious: no
Organ System: Metabolism and nutrition disorders
Frequency: 1 affected / 16 at risk

Adverse event: Nausea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 16 at risk

Adverse event: Oropharyngeal pain
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 16 at risk
Study: NCT00347776

Adverse event: 1.5 months
Serious: no
Organ System: Surgical and medical procedures
Notes: Gastrointestinal or other specific illness.Events were assessed without regard to the specific Adverse Event Term.At the 1.5-month follow-up,questions were asked from subject and all his/her family members about these adverse events.Adverse.
Frequency: 6 affected / 484 at risk

Adverse event: 1.5 months
Serious: no
Organ System: Surgical and medical procedures
Notes: Ocular complaints. At the 1.5-month follow-up,questions were asked from subject and all his/her family members about these adverse events.Adverse Events were assessed without regard to the specific Adverse Event Term.
Frequency: 7 affected / 484 at risk

Adverse event: 1.5 months
Serious: no
Organ System: Surgical and medical procedures
Notes: Gastrointestinal or other specific illness.Events were assessed without regard to the specific Adverse Event Term.At the 1.5-month follow-up,questions were asked from subject and all his/her family members about these adverse events.Adverse.
Frequency: 22 affected / 968 at risk

Adverse event: 1.5 months
Serious: no
Organ System: Surgical and medical procedures
Notes: Ocular complaints. At the 1.5-month follow-up,questions were asked from subject and all his/her family members about these adverse events.Adverse Events were assessed without regard to the specific Adverse Event Term.
Frequency: 6 affected / 968 at risk
Study: NCT00347932

Adverse event: Pneumonia
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 442 at risk

Adverse event: Pneumonia
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 432 at risk